Serving the Philadelphia-Camden-Wilmington metro area
30 of 154 GLP-1 clinics in Philadelphia prescribe semaglutide (19% of local providers). Compare pricing, insurance acceptance, and patient reviews to find the right provider.
Philadelphia has a population of 1,603,797 in the Philadelphia-Camden-Wilmington metro area. With a local obesity rate of 33.8%, demand for GLP-1 medications like semaglutide continues to grow. The city is well-served with 30 providers currently prescribing semaglutide.
Medicaid coverage: Pennsylvania Medicaid covers GLP-1 medications, which may reduce your out-of-pocket cost for semaglutide. Contact your plan to verify specific formulary coverage and prior authorization requirements.
Telehealth in Pennsylvania: Pennsylvania permits telehealth prescribing for GLP-1 medications by state-licensed providers. Both audio-visual and audio-only consultations are acceptable for follow-up visits. 12 semaglutide providers in Philadelphia offer telehealth consultations.
There are 30 clinics in Philadelphia, Pennsylvania that prescribe Semaglutide (Ozempic/Wegovy) out of 154 total GLP-1 clinics in the area. 14 of these clinics accept insurance.
Semaglutide (Ozempic/Wegovy) programs in Philadelphia typically cost between $499 and $1,249 per month. Prices depend on dosage, whether you use branded or compounded versions, and your insurance coverage. Pennsylvania Medicaid may help cover costs for eligible patients.
Yes. 12 semaglutide providers serving Philadelphia offer telehealth consultations. Pennsylvania permits telehealth prescribing for GLP-1 medications by state-licensed providers. Both audio-visual and audio-only consultations are acceptable for follow-up visits. You can complete your consultation via video call and have medication shipped to your home.
Learn about Semaglutide (Ozempic/Wegovy) – dosing, side effects, costs, and FDA approval status.
This site is for educational purposes only and is not medical advice. Always consult a healthcare provider before starting any medication. Full disclaimer
Yes. Pennsylvania Medicaid covers GLP-1 medications including semaglutide. Coverage details and prior authorization requirements vary by plan. Contact your Medicaid provider to verify semaglutide is on your formulary.
Yes. Ozempic and Wegovy (brand names for semaglutide) are FDA-approved for weight management. Your provider will determine the right dosage based on your health history and goals.
GLP-1 Medications
Compare Ozempic, Wegovy, Mounjaro, and more
